Clinical Trial Update: Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of pirfenidone in idiopathic pulmonary fibrosis has completed, with reported outcomes on its clinical performanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED